Optimind Pharma Corp.
OMND
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.40K | -85.80K | -157.10K | -663.90K | -733.80K |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 3.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 600.00 | 600.00 | -- | 426.30K | 432.80K |
| Change in Net Operating Assets | 52.40K | -140.90K | 1.10K | 92.40K | 137.90K |
| Cash from Operations | 19.60K | -226.10K | -155.90K | -145.20K | -159.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -200.00 | -11.60K |
| Cash from Investing | -- | -- | -- | -200.00 | -11.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -7.60K |
| Issuance of Common Stock | 0.00 | 270.00K | 270.00K | 270.00K | 270.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 197.20K | 197.20K | 197.20K | 191.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.60K | -29.00K | 41.20K | 51.80K | 20.60K |